Research Suggests Psychedelics Are Well Tolerated, but Calls for Improved Monitoring
Classic psychedelics like LSD and psilocybin are well-tolerated in clinical settings, with serious adverse events being rare, according to a study in JAMA Psychiatry. However, incomplete adverse event reporting highlights the need for improved safety monitoring. The study found no serious adverse events among healthy participants, but about 4% of those with neuropsychiatric disorders experienced serious events. The research emphasizes the need for rigorous pharmacovigilance practices to accurately quantify risks and benefits.
Highlighted Terms
Related News
Classic psychedelics like LSD and psilocybin are well-tolerated in clinical settings, with serious adverse events being rare, according to a study in JAMA Psychiatry. However, incomplete adverse event reporting highlights the need for improved safety monitoring. The study found no serious adverse events among healthy participants, but about 4% of those with neuropsychiatric disorders experienced serious events. The research emphasizes the need for rigorous pharmacovigilance practices to accurately quantify risks and benefits.